Viewing data from:

CLINDAMYCIN PHOSPHATE AND TRETINOIN

ANDA

CLINDAMYCIN PHOSPHATE; TRETINOIN | A202564 | ACTAVIS MID ATLANTIC LLC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: ZIANA(TE code: AB1)

Hatch-Waxman Litigation

1 case on OB patents from PACER

Case	Court	Filed	Status	Judge
Medicis Pharmaceutical Corporation et al v. Actavis Mid Atlantic LLC 1:2011cv00409 2 patentsANDA 202564Clindamycin phosphate and tretinoin	D. Del.	2011-05-11	Terminated 2013-04-12	—

Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jun 16, 2015	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 1.2%;0.025%

AB1

0 patents0 exclusivities▴

GEL;TOPICAL | Approved: Jun 12, 2015

No patent or exclusivity listings for this strength.